Creative Medical TechnologyCELZ
13F holders, Q1 2025 (March 31)11holders +3
3new positions
0sold out
$2.17avg. 13F price*
At the end of Q1 2025, 11 institutions reported holding Creative Medical Technology (CELZ) in their 13F filings, up 3 from Q4 2024. 3 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($321K), Geode Capital Management, LLC ($40K) and Vanguard Group Inc. ($38K).
- Company
- Creative Medical Technology
- CUSIP
- 22529Y408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $349K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 171,728 shares bought, net +171,728 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Armistice Capital, LLC | 0.01% | New | 148,000 | $321K |
| Geode Capital Management, LLC | 0.00% | Add +77.2% | 18,268 | $40K |
| Vanguard Group Inc. | 0.00% | No change | 17,629 | $38K |
| HRT Financial LP | 0.00% | New | 13,053 | $28K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +91.3% | 3,152 | $7K |
| Osaic Holdings, Inc. | 0.00% | Add +862.6% | 1,261 | $3K |
| Bank of America Corp. | 0.00% | No change | 122 | $264 |
| ORG Partners LLC | 0.00% | New | 80 | $160 |
| Morgan Stanley | 0.00% | No change | 20 | $43 |
| UBS Group AG | 0.00% | Add +100.0% | 2 | $4 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is CELZ's weight in each manager's 13F, not the share of Creative Medical Technology the manager owns.